Fig. 5

PFS by treatment group in frail patients (a) and nonfrail patients (b), and OS by treatment group in frail patients (c) and nonfrail patients (d) ^aP values compare with MPT. PFS Progression-Free Survival, OS Overall Survival, MPT Melphalan + Prednisone + Thalidomide